Aberdeen Group’s Corcept Therapeutics CORT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $20.4M | Sell |
278,578
-29,976
| -10% | -$2.2M | 0.03% | 405 |
|
|
2025
Q1 | $35.2M | Sell |
308,554
-127,341
| -29% | -$14.5M | 0.07% | 246 |
|
|
2024
Q4 | $22M | Sell |
435,895
-231,057
| -35% | -$11.6M | 0.04% | 347 |
|
|
2024
Q3 | $30.9M | Buy |
666,952
+142,310
| +27% | +$6.59M | 0.06% | 294 |
|
|
2024
Q2 | $17M | Buy |
+524,642
| New | +$17M | 0.03% | 416 |
|